Established 2004
BRAINSTORM CELL THERAPEUTICS INC
(NASDAQ:BCLI)
BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind stem cell therapies derived from autologous bone marrow cells for the treatment of highly debilitating neurodegenerative diseases. NurOwn™, the company’s novel stem cell technology, reprograms the patient’s mesenchymal stem cells (MSC) into highly specialized, neuron-supporting cells that are then transplanted back into the spine or muscle tissue. The company holds the rights to develop and commercialize NurOwn through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.
D&B's Credibility Mark is a seal of approval designed to reflect a level of business credibility and ease a consumer's decision making process as they move towards a business transaction. This stamp is based on our professional opinion and on the information we have as to the quality levels of the products or services offered.
